Adverse events following measles, mumps, rubella and varicella virus vaccine live (PROQUAD®) reported to the vaccine adverse event reporting system (VAERS), 2015–2025

Abstract Background PROQUAD®, a quadrivalent live-attenuated vaccine targeting measles, mumps, rubella, and varicella, is widely used in pediatric immunization programs. While clinical trials and post-marketing studies have established its general safety, real-world evidence from large-scale passive...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Guojun Liang, Qiong Liu, Yang Song
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	BMC 2025-12-01
Ráidu:	Virology Journal
Fáttát:	PROQUAD MMRV vaccine VAERS Adverse events Pharmacovigilance analysis
Liŋkkat:	https://doi.org/10.1186/s12985-025-03022-z
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!